Phototherapy Enhances Ritlecitinib Outcomes in Vitiligo Treatment
New phase 2b data shows improved repigmentation with combined light and oral therapy
Topline
Adding narrowband UVB phototherapy to oral ritlecitinib led to significantly greater repigmentation in patients with nonsegmental vitiligo, with no new safety concerns and improved patient satisfaction, according to a phase IIb extension study.
Study Details
Vitiligo is an autoimmune skin disorder causing depigmented patches due to melanocyte destr…
